Incyte Corporation (INCY) - Get Incyte Corporation (INCY) Report is expected to report quarterly earnings of 29 cents a share on sales of $488 million before the market opens Tuesday, April 30, based on a FactSet survey of 15 analysts.

In the same period a year ago, the company posted a loss of 19 cents a share on sales of $382.3 million.

The stock has fallen 10.1% since the company last reported earnings on Feb. 14.

TheStreet Recommends

Quarterly estimates have fallen less than 1 cent a share in the past month.

Incyte is currently trading at a price-to-forward-earnings ratio of 49.1 based on the 12-month estimates of 16 analysts surveyed by FactSet.

Jim Cramer and the AAP team are watching the biotechnology sector. To find out more about what stocks they like in the industry click here now to get more from Action Alerts PLUS.

Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.